News & Updates

Elevated serum progesterone levels before frozen embryo transfer (FET) in artificially prepared cycles with vaginal or vaginal plus subcutaneous progesterone have no negative impact on reproductive outcomes, as reported in a study.

Individuals who were born preterm and large for gestational age are at increased risk of atrial fibrillation (AF) up to middle age, and the risk increase is independent of familial confounding factors, according to a multinational cohort study.

The oral, small molecule Wee1 kinase inhibitor adavosertib exerts antitumour effects in patients with advanced recurrent or persistent uterine serous carcinoma, but this benefit appears to be limited by the drug’s tolerability, as shown in the single-arm, phase IIb ADAGIO study.

The addition of pembrolizumab to standard chemotherapy significantly improves progression-free survival (PFS) in patients with advanced or recurrent endometrial cancer, regardless of whether they had mismatch repair-deficient (dMMR) or mismatch repair-proficient (pMMR) disease, according to the NRG-GY018 trial presented at the SGO 2023.

Women with low levels of omega-3 in early pregnancy may lower their risk of early preterm birth by taking supplements, as suggested in a study.